Small breast epithelial mucin (SBEM) has the potential to be a marker for predicting hematogenous micrometastasis and response to neoadjuvant chemotherapy in breast cancer

Clinical and Experimental Metastasis

Volumn 27, Issue 4, 2010, Pages 251-259

  Liu, Zhao Zhe ^a   Xie, Xiao Dong ^a   Qu, Shu Xian ^a   Zheng, Zhen Dong ^a   Wang, Ya Kun ^b  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Micrometastases; Neoadjuvant chemotherapy; Small breast epithelial mucin

Indexed keywords

MESSENGER RNA; MUCIN; PACLITAXEL; SMALL BREAST EPITHELIAL MUCIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MUCL1 PROTEIN, HUMAN; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST CANCER; CANCER STAGING; CORRELATION ANALYSIS; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ADJUVANT THERAPY; BREAST TUMOR; COHORT ANALYSIS; FEMALE; GENETICS; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MUCINS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 77953251985     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9323-2     Document Type: Article

References (33)

1. Anonymous (1991) Treatment of early-stage breast cancer: NIH consensus conference. J Am Med Assoc 265:391-395
2. JW Clark L Snell BPC Shiu, et al.. 1999 The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis British J Cancer 81 1002 1008 10.1038/sj.bjc.6690799 1:CAS:528:DyaK1MXnvFSjs7c%3D (Pubitemid 29516144)
3. AL Silva J Diamond MR Silva, et al.. 2001 Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in haematological tissues Breast Cancer Res Treat 66 59 66 10.1023/A:1010628802290 1:CAS:528:DC%2BD3MXktVars7s%3D 11368411 (Pubitemid 32397943)
4. A Ring IE Smith M Dowsett 2004 Circulating tumour cells in breast cancer Lancet Oncol 5 79 88 10.1016/S1470-2045(04)01381-6 14761811 (Pubitemid 38145890)
5. T Felton GC Harris SE Pinder, et al.. 2004 Identification of carcinoma cells in peripheral blood samples of patients with advanced breast carcinoma using RT-PCR amplification of CK7 and MUC1 Breast 1 35 41 10.1016/S0960-9776(03) 00126-7 (Pubitemid 38228586)
6. N Xenidis M Perraki M Kafousi, et al.. 2006 Predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells detected by real-time polymerase chain reaction in node negative breast cancer patients J Clin Oncol 24 3756 3762 10.1200/JCO.2005.04.5948 1:CAS:528:DC%2BD28XpsVaqs78%3D 16769987 (Pubitemid 46622314)
7. V Zieglschmid C Hollmann O Böcher 2005 Detection of disseminated tumor cells in peripheral blood Crit Rev Clin Lab Sci 42 155 196 10.1080/10408360590913696 1:CAS:528:DC%2BD2MXisl2kurc%3D 15941083 (Pubitemid 41647727)
8. M Ntoulia A Stathopoulou M Ignatiadis, et al.. 2006 Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR Clin Biochem 39 879 887 10.1016/j.clinbiochem.2006.06.009 1:CAS:528:DC%2BD28Xps1GjsLg%3D 16925986 (Pubitemid 44363084)
9. RJ Miksicek Y Myal PH Watson, et al.. 2002 Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumour human mammary epithelium Cancer Res 62 2736 2740 1:CAS:528:DC%2BD38XjvFSmsbk%3D 12019145 (Pubitemid 34525752)
10. M Valladares-Ayerbes P Iglesias-Díaz S Díaz-Prado, et al.. 2009 Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: a pilot study J Cancer Res Clin Oncol 135 1185 1195 10.1007/s00432-009-0559-7 1:CAS:528:DC%2BD1MXptFCntb0%3D 19221791
11. MV Ayerbes S Díaz-Prado D Ayude, et al.. 2008 In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer Adv Exp Med Biol 617 331 339 10.1007/978-0-387-69080-3-31 18497056
12. K Jennbacken C Valbo W Wang, et al.. 2005 Expression of Vascular Endothelial Growth Factor C (VEGF-C) and VEGF Receptor-3 in human prostate cancer are associated with regional lymph node metastasis Prostate 65 110 116 10.1002/pros.20276 1:CAS:528:DC%2BD2MXhtFegt7%2FI 15880525 (Pubitemid 41362277)
13. AP Pan GY Huang J Chen, et al.. 2009 Relationship between hepatitis B virus covalently closed circular DNA and HBx protein expression in hepatocellular carcinoma and its significance World Chin J Digestol 17 712 715 1:CAS:528:DC%2BD1MXhsVOru7rI
14. GP Skliris F Hube′ I Gheorghiu, et al.. 2008 Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers Histopathology 52 355 369 10.1111/j.1365-2559.2007. 02955.x 1:STN:280:DC%2BD1c7htVChtw%3D%3D 18269587 (Pubitemid 351208066)
15. M Luppi M Morselli E Bandieri, et al.. 1996 Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene Ann Oncol 7 619 624 1:STN:280:DyaK2s%2FjtlOiuw%3D%3D 8879377 (Pubitemid 26285643)
16. TJ Molloy AJ Bosma J van't Veer Laura 2008 Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor cells Breast Cancer Res Treat 112 297 307 10.1007/s10549-007-9872-5 1:STN:280:DC%2BD1cnlvVeltw%3D%3D 18213476
17. DG Ginzinger 2002 Gene quantification using real-time quantitative PCR: An emerging technology hits the mainstream Exp Hematol 30 503 512 10.1016/S0301-472X(02)00806-8 1:CAS:528:DC%2BD38XksFOksb8%3D 12063017 (Pubitemid 34626648)
18. M Lacroix 2006 Significance, detection and markers of disseminated breast cancer cells Endocr Relat Cancer 13 1033 1067 10.1677/ERC-06-0001 1:CAS:528:DC%2BD2sXisFaktrY%3D 17158753 (Pubitemid 46212562)
19. M Cristofanilli DF Hayes GT Budd, et al.. 2005 Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer J Clin Oncol 23 1420 1430 10.1200/JCO.2005.08.140 15735118 (Pubitemid 46260029)
20. P Wülfing J Borchard H Bürger, et al.. 2006 HER2-positive circulating tumor cells indicate poor clinical outcome in stages I to III breast cancer patients Clin Cancer Res 12 1715 1720 10.1158/1078-0432.CCR-05-2087 16551854
21. F Hube M Mutawe E Leygue, et al.. 2004 Human small breast epithelial mucin: the promise of a new breast tumour biomarker DNA Cell Biol 23 842 894 1:CAS:528:DC%2BD2cXhtFWqsLvF 15684711 (Pubitemid 39628292)
22. NM Brown TT Stenzel PN Friedman, et al.. 2006 Evaluation of expression based markers for the detection of breast cancer cells Breast Cancer Res Treat 97 41 47 10.1007/s10549-005-9085-8 16319979 (Pubitemid 43750947)
23. AM Gilbey D Burnett RE Coleman, et al.. 2004 The detection of circulating breast cancer cells J Clin Pathol 57 903 911 10.1136/jcp.2003.013755 1:STN:280:DC%2BD2cvivVChtw%3D%3D 15333648 (Pubitemid 39208239)
24. MP Leers RH Schoffelen JG Hoop, et al.. 2002 Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer J Clin Pathol 55 359 366 10.1136/mp.55.6.359 1:STN:280:DC%2BD383ot1OmsA%3D%3D 11986342
25. S Beriwal GF Schwartz L Komarnicky, et al.. 2006 Breast conserving therapy after neoadjuvant chemotherapy: long term results Breast J 12 159 164 10.1111/j.1075-122X.2006.00225.x 16509842
26. S Amat C Abrial F Penault-Llorca, et al.. 2005 High prognostic significance of residual disease after neoadjuvant chemotherapy: a retrospective study in 710 patients with operable breast cancer Breast Cancer Res Treat 94 255 263 10.1007/s10549-005-9008-8 1:CAS:528:DC%2BD2MXht1Cqt7jN 16267618 (Pubitemid 41677630)
27. XD Xie SX Qu 2007 Neoadjuvant chemotherapy in breast cancer Chin J Pract Inter Med 27 1904 1907 1:CAS:528:DC%2BD1cXjsFyrs7k%3D
28. GF Schwartz AJ Meltzer EA Lucarelli, et al.. 2005 Breast conservation after neoadjuvant chemotherapy for stage II carcinoma of the breast J Am Coll Surg 201 327 334 10.1016/j.jamcollsurg.2005.03.015 16125064 (Pubitemid 41206769)
29. BT Hennessy AM Gonzalez-Angulo GN Hortobagyi 2005 Individualization of neoadjuvant therapy for breast cancer according to molecular tumor characteristics Nat Clin Pract Oncol 2 598 599 10.1038/ncponc0375 16341096 (Pubitemid 43179716)
30. M Wu JX Zhang LQ Pang, et al.. 2007 Clinical significance of SBEM mRNA assay in peripheral blood from patients with breast cancer J Jiangsu Univ (Med Edition) 17 241 243 1:CAS:528:DC%2BD2sXhsVCgtr%2FE
31. HW Yang JL Liu J Cao, et al.. 2005 The Studies on SBEM-mRNA and CD44V6-mRNA in Peripheral Blood of Patients with Breast Cancer Chin J Clin Oncol 32 382 385 1:CAS:528:DC%2BD28Xisl2ls78%3D (Pubitemid 40733012)
32. F Ke JM Wu JE Yao, et al.. 2007 Application of suspension array assay to detect marker genes expression of circulating tumor cells for early prediction of breast cancer metastasis Zhonghua Yi Xue Za Zhi 87 2257 2261 1:CAS:528:DC%2BD1cXhtFCmt7zN 18001545 (Pubitemid 350018116)
33. A Ho-Pun-Cheung C Bascoul-Mollevi E Assenat, et al.. 2009 Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization BMC Mol Biol 10 31 10.1186/1471-2199-10-31 10.1186/1471-2199-10-31 19368728